On November 11, 2025, Dmitry Bolotov, Director of International Sales of the Pharmasyntez Group, met with Professor Koy Vanny, the Secretary of State for Public Relations and Quality of Services at the Ministry of Health of the Kingdom of Cambodia. Key aspects of starting an investment project to build a pharmaceutical manufacturing facility for the production of antitumor medications in Cambodia were discussed by the.



The project aims to build a cutting-edge pharmaceutical complex and transfer drug manufacturing technology from Pharmasyntez's Russian site in stages, beginning with secondary packaging and moving up to higher levels of localization. The initiative, which aims to attract foreign investment, entails signing an off-take agreement with Cambodia's Ministry of Health for the long-term supply of safe, effective, and high-quality pharmaceutical products.

The parties acknowledged the project's strategic significance for advancing Cambodia's pharmaceutical infrastructure and raising the standard of medical care for cancer patients.